Increased sympathetic nerve activity in renovascular hypertension

Circulation

Volumn 99, Issue 19, 1999, Pages 2537-2542

  Johansson, Mats ^a   Elam, Mikael ^a   Rundqvist, Bengt ^a   Eisenhofer, Graeme ^b   Herlitz, Hans ^a   Lambert, Gavin ^a   Friberg, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b National Institute of Neurological Disorders   (United States)

Author keywords

Hypertension; Nervous system; Renin; Sympathetic

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NORADRENALIN; RENIN; TRITIUM;

ADRENERGIC SYSTEM; ADULT; ANGIOPLASTY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY; KIDNEY ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SYMPATHETIC TONE;

EID: 0033580596     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.19.2537     Document Type: Article

References (31)

1. Swales J. Textbook of Hypertension. Oxford, UK: Blackwell Scientific Publications; 1994:477-493.
2. Brown JJ, Davies DL, Morton JJ, Robertson JI, Cuesta V, Lever AF, Padfield PL, Trust P. Mechanism of renal hypertension. Lancet. 1976;1: 1219-1221.
3. Suzuki H, Ferrario CM, Speth RC, Brosnihan KB, Smeby RR, de Silva P. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs. Hypertension. 1983;5:I-139-I-148.
4. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension. 1991;17: 1057-1062.
5. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
6. Vallbo Å, Hagbarth K-E, Torebjàrk H, Wallin B. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev. 1979;59:919-957.
7. Sundlöf G, Wallin B. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol. 1977;272:382-397.
8. Wallin B, Elam M. Microneurography and autonomie dysfunction. In: Low P, ed. Clinical Autonomous Disorders: Evaluation and Management. 2nd ed. Boston, Mass: Little Brown & Co; 1997:233-243.
9. Wallin B, Elam M. Insights in intraneural recordings of sympathetic nerve traffic in humans. News Physiol Sci. 1994;9:7-11.
10. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-2033.
11. Giese J, Aurell M, Munck O. Peripheral and renal venous plasma renin concentrations in hypertensive patients with unilateral renal or reno-vascular disease. Scand J Urol Nephrol. 1972;6(suppl 15):39-47.
12. Kappelgaard A, Damker Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chem Acta. 1976;67:299-306.
13. Morton J, Webb D. Measurement of plasma angiotensin II. Clin Sci. 1985;68:483-484.
14. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470.
15. Esler M, Jennings G, Biviano B, Lambert G, Hasking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986;8:539-544.
16. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens. 1993;11: 647-655.
17. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest. 1993;92:25-28.
18. Katholi R. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol. 1983;14:F1-F14.
19. Brody MJ, Varner KJ, Vasquez EC, Lewis SJ. Central nervous system and the pathogenesis of hypertension: sites and mechanisms. Hypertension. 1991;18:III-7-III-12. Review.
20. Majewski H, Hedler L, Schurr C, Starke K. Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol. 1984;6:888-896.
21. Converse R Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
22. Friberg P, Meredith I, Jennings G, Lambert G, Fazio V, Esler M. Evidence for increased renal norepinephrine overflow during sodium restriction in humans. Hypertension. 1990;16:121-130.
23. Krekels M, Schaper N, de Leeuw P. Sensitivity of blood pressure and renin activation during sodium restriction. Hypertension. 1997;30:1216-1222.
24. Goldsmith SR. Effect of amlodipine and felodipine on sympathetic activity and baroreflex function in normal humans. Am J Hypertens. 1995;8:902-908.
25. Lindqvist M, Kahan T, Melcher A, Hjemdahl P. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. Hypertension. 1994;24:287-296.
26. Cambria R, Brewster D, L'Italien G, Gertler J, Abbot W, LaMuraglia G, Moncure A, Vignati J, Bazari H, Fang L, Atamian S. Renal artery reconstruction for the preservation of renal function. J Vasc Surg. 1996; 24:371-382.
27. Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, McCants CB Jr, Mark DB, Bashore TM, Albers F. Survival in renovascular disease. J Am Soc Nephrol. 1998;9:252-256.
28. Isles C, Main J, O'Connell J, Brown I, Findlay J, Stewart R, Wilkinsson R. Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study. Scott Med J. 1990;35:70-73.
29. Mathias CJ, Wilkinson A, Lewis PS, Peart WS, Sever PS, Snell ME. Clonidine lowers blood pressure independently of renin suppression in patients with unilateral renal artery stenosis. Chest. 1983;83:357-359.
30. Kooner JS, Peart WS, Mathias CJ. The sympathetic nervous system in hypertension due to unilateral renal artery stenosis in man. Clin Auton Res. 1991;1:195-204.
31. Esler M. High blood pressure management: potential benefits of II agents. J Hypertens Suppl. 1998;16:S19-S24.